Hematology/Oncology

Dhaval Shah

Accepts Medicare (pay less out of pocket)

Address

4701 Ogletown Stanton Rd,

Suite 3400,

Newark 19713-7007, DE

Phone

(302) 366-1200

About Dr. Dhaval Shah

With a distinguished career spanning since 2006 , Dr. Dhaval Shah has established himself as a respected Hematology/Oncology specialist. Dr. Shah brings exceptional expertise to Delaware Hospice - North Division. He is known for his comprehensive approach to patient care and dedication to medical excellence. Located at 4701 Ogletown Stanton Rd, Newark, DE 19713-7007, Dr. Shah's practice offers telehealth services and welcomes new patients. For appointments, please call (302) 366-1200.

Details

Specialty

Hematology/Oncology

Gender

M

Medical School

Other

Graduation Year

2006

Offers Telehealth Services

Yes

Accepts Medicare Assignment

Yes

Facility / Group Affiliations

Facility Type

Hospice

Facility

DELAWARE HOSPICE - NORTH DIVISION

Facility Type

Hospital

Facility

CHRISTIANA HOSPITAL

Facility Type

Group

Group Name

MEDICAL ONCOLOGY HEMATOLOGY CONSULTANTS PA

Member Count

19

Accepts Medicare Assignment

Y

Quality Payment Program (QPP) Performance

MIPS Measure

Implementation of medication management practice improvements

Attestation

Yes

MIPS Measure

Advance Care Planning

Attestation

Yes

MIPS Measure

Advance Care Plan

Attestation

No

MIPS Measure

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan

Attestation

No

MIPS Measure

Documentation of Current Medications in the Medical Record

Attestation

No

MIPS Measure

Oncology: Medical and Radiation - Plan of Care for Pain

Attestation

No

MIPS Measure

Oncology: Medical and Radiation Pain Intensity Quantified

Attestation

No

MIPS Measure

Controlling High Blood Pressure

Attestation

No

MIPS Measure

e-Prescribing

Attestation

No

MIPS Measure

Query of the Prescription Drug Monitoring Program (PDMP)

Attestation

Yes

MIPS Measure

Support Electronic Referral Loops By Receiving and Reconciling Health Information Exclusion

Attestation

Yes

MIPS Measure

Support Electronic Referral Loops By Sending Health Information Exclusion

Attestation

Yes

MIPS Measure

ONC Direct Review Attestation

Attestation

Yes

MIPS Measure

Provide Patients Electronic Access to Their Health Information

Attestation

No

MIPS Measure

Syndromic Surveillance Reporting Exclusion

Attestation

Yes

MIPS Measure

Clinical Data Registry Reporting

Attestation

Yes

MIPS Measure

Security Risk Analysis

Attestation

Yes

MIPS Measure

Oncology: Advance Care Planning in metastatic cancer patients

Attestation

No

MIPS Measure

Oncology: Patient-reported pain improvement

Attestation

No

Clinician Utilization Performance Scores

Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour

Practice State: DE

Line Service Count: 82

Beneficiary Count: 42

Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour

Practice State: DE

Line Service Count: 302

Beneficiary Count: 51

Injection beneath the skin or into muscle for therapy, diagnosis, or prevention

Practice State: DE

Line Service Count: 75

Beneficiary Count: 18

Injection of different drug or substance into a vein for therapy, diagnosis, or prevention

Practice State: DE

Line Service Count: 530

Beneficiary Count: 62

Infusion of chemotherapy into a vein up to 1 hour

Practice State: DE

Line Service Count: 584

Beneficiary Count: 87

Injection, denosumab, 1 mg

Practice State: DE

Line Service Count: 8760

Beneficiary Count: 25

Injection, dexamethasone sodium phosphate, 1 mg

Practice State: DE

Line Service Count: 3028

Beneficiary Count: 53

Injection, fosaprepitant, 1 mg

Practice State: DE

Line Service Count: 16050

Beneficiary Count: 25

Injection, palonosetron hcl, 25 mcg

Practice State: DE

Line Service Count: 2110

Beneficiary Count: 38

Locations

4701 Ogletown Stanton Rd
Suite 3400
Newark, DE 19713 -7007
Phone: (302) 366-1200

Get Directions